Biodesix, Inc. BDSX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -31.5%+16.9pp | -48.4%+35.9pp | -84.2%+48.2pp | -132.4%-57.3pp | |
| Net margin | -39.8%+20.3pp | -60.2%+46.0pp | -106.2%+65.0pp | -171.3%-92.1pp | |
| Returns | |||||
| Return on invested capital | -51.6%+20.6pp | -72.2%+99.1pp | -171.3%— | —— | |
| Efficiency | |||||
| Asset turnover | 1×+0.2× | 0.7×+0.2× | 0.5×+0.1× | 0.5×-0.1× | |
| Liquidity | |||||
| Current ratio | 1.9×-0.9× | 2.8×+1.6× | 1.2×-1.1× | 2.3×+0.8× | |
| Per Share | |||||
| Book value per share | -$0.33-110% | $3.23+5,682% | $0.06-88.6% | $0.49-32.1% | |
| Valuation | |||||
| Market capitalization | $233.52M+476% | $222.56M+31.0% | $169.88M+27.8% | $132.95M-19.1% | |
| Price / sales | 2.4×+1.9× | 3.1×-0.3× | 3.5×0.0× | 3.5×+0.5× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Biodesix, Inc.'s ratios come from?
- Every ratio is computed from Biodesix, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
